| 000 | 01590 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513231046.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.2001.4328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIrahara, M | |
| 245 | 0 | 0 |
_aOrexin-A suppresses the pulsatile secretion of luteinizing hormone via beta-endorphin. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cFeb 2001 |
||
| 300 |
_a232-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarrier Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndorphins _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 |
_aNaloxone _xadministration & dosage |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aNeuropeptides _xadministration & dosage |
| 650 | 0 | 4 | _aOrexins |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aTamura, T | |
| 700 | 1 | _aMatuzaki, T | |
| 700 | 1 | _aSaito, S | |
| 700 | 1 | _aYasui, T | |
| 700 | 1 | _aYamano, S | |
| 700 | 1 | _aKamada, M | |
| 700 | 1 | _aAono, T | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 281 _gno. 1 _gp. 232-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2001.4328 _zAvailable from publisher's website |
| 999 |
_c11117364 _d11117364 |
||